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Developing cardiac myocytes divide a limited number of times before they stop and terminally differentiate, but the
mechanism that stops their division is unknown. To help study the stopping mechanism, we defined conditions under
which embryonic rat cardiac myocytes cultured in serum-free medium proliferate and exit the cell cycle on a schedule that
closely resembles that seen in vivo. The culture medium contains FGF-1 and FGF-2, which stimulate cell proliferation, and
thyroid hormone, which seems to be necessary for stable cell-cycle exit. Time-lapse video recording shows that the cells
within a clone tend to divide a similar number of times before they stop, whereas cells in different clones divide a variable
number of times before they stop. Cells cultured at 33°C divide more slowly but stop dividing at around the same time as
cells cultured at 37°C, having undergone fewer divisions. Together, these findings suggest that an intrinsic timer helps
control when cardiac myocytes withdraw from the cell cycle and that the timer does not operate by simply counting cell
divisions. We provide evidence that the cyclin-dependent kinase inhibitors p18 and p27 may be part of the timer and that
thyroid hormone may help developing cardiac myocytes stably withdraw from the cell cycle. © 1999 Academic PressKey Words: cell cycle; timer; culture; heart; differentiation.
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nINTRODUCTION
In most mammalian cell lineages precursor cells divide a
limited number of times before they terminally differenti-
ate into cells that do not divide again. In none of these cases
do we know the mechanisms that stop cell division and
initiate terminal differentiation. The stopping mechanisms
are important because they influence how many differenti-
ated cells are produced and when terminal differentiation
occurs.
Cardiac myocytes are produced from dividing precursor
cells that come from the lateral plate mesoderm (for review
see Fishman and Olson, 1997; Olson and Srivastava, 1996).
The precursors first differentiate into immature contractile
myocytes, which continue to divide. These myocytes then
withdraw from the cell cycle and grow. Although adult
myocytes do not divide, neonatal cardiac myocytes are able
to replicate their DNA and undergo mitosis without cyto-
kinesis to become multinucleate (Rumyantsev, 1978).
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All rights of reproduction in any form reserved.In the rat, the first beating myocytes appear in the
eveloping heart at embryonic day 8 (E8), and new ones
ontinue to appear until late fetal life. Cell proliferation
eases soon after birth, so that myocyte number increases
0-fold between E15 and postnatal day 1 (P1) and 2-fold
etween P1 and P3 (Li et al., 1996; Winick and Noble, 1965;
nesco and Leblond, 1962) and thereafter remains constant.
ubsequent heart growth depends entirely on cell enlarge-
ent (Chien et al., 1991). Here we provide evidence that
ividing rat cardiac myocytes have a cell-intrinsic timing
echanism that influences when the cells stop dividing
nd terminally differentiate.
Previous evidence for such an intrinsic timer has come
rom studies of oligodendrocyte precursor cells isolated
rom the developing rodent optic nerve (reviewed in Raff et
l., 1998). These precursor cells migrate into the developing
erve from the brain, divide a limited number of times, and
hen terminally differentiate into postmitotic oligodendro-
ytes, which myelinate the axons in the nerve. The normal
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660 Burton et al.timing of oligodendrocyte development can be reconsti-
tuted in cultures of dissociated perinatal rat optic nerve
cells (Raff et al., 1985, 1988). Clonal analyses in culture
suggest that both a cell-intrinsic mechanism and extracel-
lular signals play important parts in determining when the
precursor cells stop dividing and differentiate: in the pres-
ence of appropriate signaling molecules, the precursor cells
divide up to eight times before they stop and terminally
differentiate, and the progeny of an individual precursor cell
tend to stop dividing and differentiate at about the same
time (Temple and Raff, 1986). Moreover, when the two
daughter cells of an individual precursor cell are separated
and stimulated to divide in separate microwells, they tend
to divide the same number of times, suggesting that an
intrinsic mechanism limits their proliferation (Temple and
Raff, 1985). When precursor cells are cultured at 33°C rather
than 37°C, they divide more slowly but differentiate sooner,
after fewer cell divisions, suggesting that the intrinsic
mechanism does not operate by simply counting cell divi-
sions but instead measures elapsed time in some other way
(Gao et al., 1997). Although this timer is cell intrinsic, it
epends on signals from other cells to operate normally,
ncluding the mitogen platelet-derived growth factor
PDGF) (Noble et al., 1988; Raff et al., 1988; Richardson et
al., 1988) and hydrophobic signals, such as thyroid hormone
(triiodothyroinine, T3) (Baas et al., 1997; Ibarrola et al.,
1996; Ahlgren et al., 1997; Barres et al., 1994). In the
absence of PDGF, cultured precursor cells prematurely stop
dividing and terminally differentiate within 2 days (Temple
and Raff, 1985; Noble and Murray, 1984) whether or not
hydrophobic signals are present (Ahlgren et al., 1997; Barres
et al., 1994). In the presence of PDGF but in the absence of
hydrophobic signals, most of the precursor cells tend to
keep dividing and do not differentiate (Barres et al., 1994).
There is evidence that the timer (Barres and Raff, 1994;
Bogler and Noble, 1994) consists of at least two compo-
nents: a timing component that measures elapsed time
independent of T3 and an effector component that is
regulated by T3 and stops cell proliferation and initiates
differentiation when the timing component indicates it is
time (Barres et al., 1994b).
In the present study we have investigated whether divid-
ing cardiac myocytes have a similar timer that regulates
how long they proliferate. We first developed a serum-free
culture system in which the timing of E15 rat myocyte
proliferation resembles that seen in vivo, and then we used
ime-lapse video recording to perform clonal analyses to
tudy the effects of T3 and low temperature on the prolif-
rative behavior of the cells. In addition, we examined the
xpression of the cyclin-dependent kinase (CDK) inhibitor
27Kip1 (p27) protein during cardiac myocyte cell cycle exit,
the proliferation of cardiac myocytes isolated from p27
deficient mice, and the effect of T3 on the expression of
various CDK inhibitors including p27. Our findings suggest
that cardiac myocytes have an intrinsic timer with proper-
w
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Copyright © 1999 by Academic Press. All rightties similar to those of the timer that operates in oligoden-
drocyte precursor cells, and, like the latter timer, it seems
to depend on p27 for its normal operation.
METHODS
Materials. All reagents were from Sigma (Poole, UK) unless
stated otherwise. Growth factors were from R & D Systems
Abingdon, UK).
p272/2 mice. p272/2 mice were produced by breeding
271/2 males and females. Genotyping was performed by PCR
sing tail DNA as described by Fero et al. (1996). p272/2 mice
were identified using primers N1 (CCTTCTATGGCCTTCTT-
GACG) and K3 (TGGAACCCTGTGCCATCTCTAT) to detect the
presence of a 0.5-kb PCR fragment unique to the mutant transgene
and by using primers K3 and K5 (GAGCAGACGCCCAAGAAGC)
to detect the absence of the corresponding 0.9-kb fragment unique
to the wild-type allele.
Cell preparation. Cardiac myocytes were prepared from fetal
Sprague–Dawley rats or from wild-type or p272/2 C57BJ6 black
mice. Female time-mated rats or mice were sacrificed using carbon
dioxide inhalation and cervical dislocation. Fetuses were removed
and placed into ice-cold phosphate-buffered saline (PBS, pH 7.4).
The heats were removed, placed in Ca21-free PBS at 4°C, washed
nce in the same medium, and then incubated in a solution of type
I collagenase (Worthington; 1 mg/ml in the same medium, typi-
ally 30 hearts in 10 ml) for 22 min. The hearts were then gently
riturated using a Pasteur pipette until all tissue fragments disap-
eared. The resulting cell suspension was then mixed with an equal
olume of Dulbecco’s modified Eagle’s medium (DMEM) contain-
ng 10% (v/v) fetal calf serum (FCS) and centrifuged at 700g for 6
in. The cell pellet was resuspended in DMEM–FCS containing 2
M L-glutamine, penicillin (100 U/ml), streptomycin (0.1 mg/ml),
and amphotericin B (0.25 mg/ml) and passed sequentially through a
21- and a 25-gauge needle. About 5 3 106 cells were plated in 20 ml
of culture medium in a 75-cm2 tissue culture flask (Falcon) for 1 h
to allow the nonmyocytes to adhere. The nonadherent cells were
then placed in another flask for a further hour. The nonadherent
cells were then plated at 2 3 104 cells per well into 24-well plates
(Falcon), which had been previously coated with a solution of 1%
(w/v) gelatin in water. These myocyte preparations were .98%
pure as judged by immunocytochemical staining with monoclonal
antibodies against sarcomeric actin (Sigma; diluted 1/500) or
troponin-I (Sasse et al., 1993) (kindly provided by G. K. Dhoot and
iluted 1/500). At least 70% of the cells were beating on the day
fter plating.
Cardiac myocyte culture. The myocytes were cultured in
MEM–FCS overnight at 37°C in 5% CO2. They were then washed
everal times with warm, serum-free DMEM containing 0.1 mg/ml
SA, 2 mM L-glutamine, penicillin, streptomycin, amphotericin B,
-acetylcysteine (60 mg/ml), insulin (5 mg/ml), transferrin (5 ng/
l), and sodium selenite (5 ng/ml). The cells were then cultured in
his serum-free medium, with additional hormones or growth
actors where indicated. In some experiments, myocytes were
ultured in DMEM–FCS without rinsing in serum-free medium.
fter various time periods, cells were removed from the culture
ish with trypsin (0.5 mg/ml) and EDTA (0.2 mg/ml) and counted
n a Coulter counter (Coulter, UK; Model ZN). In experiments in
hich cells were cultured in DMEM–FCS for prolonged periods,
he cells were passaged when they were approximately 70–80%
s of reproduction in any form reserved.
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661Timing of Cell-Cycle Withdrawal in Cardiac Myocytesconfluent; the cells were removed from the dish with trypsin
and EDTA, counted, and replated in six-well culture dishes
(Falcon) at a low density, to ensure that they did not become
confluent again. In experiments carried out at 33°C, cells were first
allowed to attach overnight at 37°C; they were then rinsed and
cultured at 33°C.
Time-lapse video microscopy. Myocytes were cultured at low
ensity (2 3 104 cells in 7 ml of medium) in 25-cm2 tissue culture
flasks (Falcon). After the flasks were gassed with 5% CO2/95% air,
the caps were tightened and the flasks were placed on a heated
stage of a Nikon Diaphot inverted microscope, equipped with a
video camera (JVC; Model TK-S350) and time-lapse video recorder
(JVC; Model BR-9020E). Half the medium was replaced and the
flasks were regassed every 4 days.
Western blot analysis. Whole hearts and cultured myocytes
were homogenized in lysis buffer (1% SDS (v/v) in water, 1 mM
PMSF, 10 mg/ml aprotinin, and 10 mg/ml leupeptin). The extracts were
nalyzed by SDS–PAGE and Western blotting, as described previously
Burton et al., 1999). Blots were probed with affinity-purified antibod-
es directed against FGF-1 (Santa Cruz; diluted 1/1000), FGF-2 (Onco-
ene Research Products; 1 mg/ml), p18 (Santa Cruz; diluted 1/1000), or
Glut-4 (Santa Cruz; diluted 1/1000) or with a monoclonal anti-p27
antibody (Transduction Laboratories, 1 mg/ml) and developed using an
ECL kit (Amersham, UK). To ensure equal protein loading of lanes,
blots were also probed with a monoclonal antibody directed against
sarcomeric actin (Sigma; diluted 1/1000).
Immunocytochemistry and confocal microscopy. Immuno-
staining for p27 was performed as described (Thomas et al., 1998).
Cells were grown in two-well chamber slides (Nunc). The cells were
fixed in 4% phosphate-buffered formalin (pH 7.4), microwaved for 4 3
5 min in sodium citrate buffer, and stained with the monoclonal
anti-p27 antibody (diluted 1/800) for 2 h, followed by a fluorescein-
coupled goat anti-mouse IgG antibody (Dako; diluted 1/100) for 1 h.
Confocal immunofluorescence microscopy was performed as de-
scribed previously (Vozzi et al., 1999), with the intensity of p27
staining being measured and expressed in arbitrary units (pixels).
For bromodeoxyuridine (BrdU) incorporation, cultures were fed
with media containing BrdU (10 mM) for 2 h. Cells were then fixed
and immunostained as described above, using a monoclonal anti-
body directed against BrdU (Amersham), as described by the
manufacturer.
Statistical analysis. Significance was assessed between groups
where appropriate using Student’s t test, with a P value ,0.05 being
aken as significant. For statistical analysis of differences in clone size
etween groups, an F test of analysis of variance was used, with a P
alue ,0.05 being taken as significant. Fisher’s exact test was applied
o examine the significance of cells exiting the cell cycle together in
edigree analyses, and a P value ,0.05 was taken as significant.
RESULTS
Excessive Myocyte Proliferation in Cultures
Containing 10% FCS
Normally, cardiac myocytes from E15 rats proliferate in
ivo for about 10 days and increase in number 15- to 20-fold
Li et al., 1996; Winick and Noble, 1965; Enesco and
eblond, 1962). In contrast, when E15 rat cardiac myocytes
ere cultured at low density in medium containing 10%
CS and passaged on reaching 70–80% confluency, the
Copyright © 1999 by Academic Press. All rightells proliferated for around 20–25 days and increased at
east 50-fold in number over a 20-day period (Fig. 1). E20
ells increased only 5-fold over the same time period while
12 cells increased 150-fold. These findings suggest that the
roliferative capacity of embryonic cardiac myocytes de-
reases with developmental age and that in the presence of
0% FCS these cells proliferate in vitro far longer than they
ormally do in vivo.
Normal Proliferation in Serum-Free Cultures
Containing FGF and Thyroid Hormone
In order to find conditions under which the proliferation
of E15 myocytes in vitro more closely resembles that seen
in vivo, we tested a variety of culture conditions and growth
factors. We obtained best results with serum-free DMEM
supplemented with N-acetylcysteine, BSA, insulin, trans-
ferrin, sodium selenite, FGF-1 (25 ng/ml) and FGF-2 (25
ng/ml), and T3 (30–100 nM). Western blot analysis of heart
extracts confirmed that both these FGFs are present in fetal
rat heart and that their abundance progressively increases
during development between E12 and P10 (Fig. 2).
In this culture medium the number of E15 cardiac myo-
cytes increased 15- to 20-fold, reaching a plateau after 10
days (Fig. 3A), which closely resembles their behavior in
vivo. The presence or absence of T3 had relatively little
effect on proliferation, although cells reached a somewhat
FIG. 1. Cardiac myocytes proliferate excessively when cultured
in serum-containing medium. Cells were prepared from E12, E15,
or E21 rats, and 2 3 104 cells were plated per dish. After the
ndicated time period, cells were trypsinized and counted. In this
nd subsequent figures the number of cells was determined using a
oulter counter, which counted between 103 and 104 cells. The
identity of cardiac myocytes in representative cultures was con-
firmed using antibodies directed against sarcomeric actin and
cardiac troponin-I. Data are shown as means 6 SE of four cultures.
The experiment was repeated three times with similar results.higher plateau value in the presence of T3 (Fig. 3A). On the
day after plating, cultures contained .98% actin-positive
s of reproduction in any form reserved.
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662 Burton et al.cardiac myocytes (Fig. 3B). After 9 days, the cultures con-
tained at least 85% actin-positive cardiac myocytes. E21
myocytes proliferated very little (Fig. 3A), as would be
expected if they behaved as in vivo. In some experiments,
cultures were labeled for 2 h with BrdU after 9 days in
culture. Fewer than 1% of the cells were labeled, confirm-
ing that cell proliferation had largely ceased.
When we cultured E15 cells in the presence of T3 for 11
days and then switched them to DMEM–FCS the cells did
not increase in number (Fig. 3C), suggesting that they had
permanently exited the cell cycle. Cells cultured in the
same medium, but without T3, however, increased in
number when switched to DMEM–FCS (Fig. 3C), suggesting
that T3 helps the cells permanently stop dividing. When we
cultured E15 cells in serum-free medium but without FGFs
or T3, the cells did not proliferate, but when switched after
11 days to DMEM–FCS they proliferated extensively (data
not shown), indicating that they had not stably withdrawn
from the cell cycle in the absence of mitogens.
The average size of the myocytes in FGF- and T3-
supplemented serum-free medium did not change during 10
days in culture. However, when 10% FCS was added after
10 days, although cell proliferation did not occur, the cells
promptly increased in size (Fig. 4). In addition, the expres-
sion of the glucose transporter Glut-4, which has been
shown to increase as cardiac myocytes differentiate (Santa-
lucia et al., 1992), increased (Fig. 4). These findings suggest
that in serum-free medium containing FGFs and T3, cardiac
myocytes proliferate and differentiate on a schedule that
resembles that seen in vivo, and, after an appropriate
nterval, they lose their ability to proliferate but can hyper-
rophy and further differentiate in response to FCS.
Interclonal Heterogeneity in Proliferative Capacity
Assessed by Clone Size
FIG. 2. Western blot analyses of FGFs in perinatal rat heart extracts.
The proteins in the extracts were separated by SDS–PAGE, blotted
onto nitrocellulose, and probed with affinity-purified antibodies
against FGF-1 and FGF-2. The same amount of total protein (30 mg)
as loaded in each lane. The numbers on the left indicate the size and
osition of molecular weight markers in kilodaltons.To study the proliferative behavior of individual myo-
cytes, we cultured E15 or E21 cells at clonal density in
r
a
Copyright © 1999 by Academic Press. All rightither DMEM–FCS or the serum-free medium containing
GFs and T3. After 7 days, we determined the number of
ells per clone. This analysis showed that the myocytes
ere very heterogeneous in their proliferative capacity; it
lso confirmed that, on average, E15 cells proliferated more
han E21 cells, and both E15 and E21 cells divided more in
erum-containing than in the serum-free medium (Fig. 5).
Intraclonal Homogeneity Assessed by Time-Lapse
Video Recording
To study the behavior of myocytes within clones we used
time-lapse video recording to continually monitor cells
maintained in serum-free culture medium in the presence
of FGFs and T3. In this way we could follow every cell
division and cell death for cells within individual clones
(although some cells migrated out of the microscopic field
and were lost to further analysis). Fourteen typical clones of
E15 cardiac myocytes that we followed for a period of 7–10
days are shown in Fig. 6A. Although there was great
variation in the overall proliferative capacity of individual
clones, there was a striking tendency for cells within a
clone to behave in the same way; the two daughter cells
produced by a cell division tended to divide again at around
the same time. The average difference in time between
sibling divisions was 5.45 6 1.66 h (mean 6 SE). No
significant difference was found between the cell-cycle
lengths of siblings (P 5 0.11, Student’s t test). Furthermore,
ells within a clone tended to stop dividing at around the
ame time (Fig. 6A). We obtained similar results when we
tudied E12 and E21 cardiac myocytes by time-lapse video
ecording, in that the daughter cells produced by a cell
ivision tended to go through the same number of subse-
uent divisions before they stopped dividing. In agreement
ith the data shown in Fig. 1 the maximum number of
ivisions that the E15 cells underwent was 7, the maximum
umber of division that the E12 and E21 cells underwent
ere 9 and 3, respectively (data not shown). Considering all
ell divisions in the pedigrees in which the fate of both
aughter cells was clear (i.e., excluding those in which one
as lost from the field of view), of 44 divisions, 39 (83%)
roduced cells which behaved the same way, 5 (17%)
roduced cells which behaved differently (P , 0.001; Fish-
r’s exact test). These findings strongly suggest that the
yocytes have an intrinsic mechanism that limits their
roliferation, at least under these culture conditions.
Occasionally, two daughter cells divided at very different
imes. When this occurred, the cell divisions that produced
he two cells were found to be asymmetrical, producing one
arge and one small cell, with the larger one always dividing
rst. This finding suggests that the myocytes have to reach
threshold size before they can divide, as previouslyeported for oligodendrocyte precursor cells using a similar
ssay (Gao and Raff, 1997).
s of reproduction in any form reserved.
culture medium containing FGFs with or without T3. 2 3 104 cells
were plated into each well of a 24-well culture plate in DMEM– w
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Copyright © 1999 by Academic Press. All rightEffect of Lowering the Temperature to 33°C
To help determine whether the intracellular mechanism
that limits cell proliferation in cardiac myocytes counts cell
divisions or measures time in some other way, we com-
pared the behavior of cells cultured in serum-free medium
at 33°C with their behavior at 37°C, as done previously for
mouse embryo fibroblasts (Ikram et al., 1994) and for
oligodendrocyte precursor cells (Gao et al., 1997). As ex-
pected, when cell-cycle times were measured by time-lapse
video recording, the cells at 33°C divided more slowly than
the cells at 37°C (Fig. 6B). Although the cells at 33°C
stopped proliferating around the same time as those at
37°C, the cells at 33°C went through fewer divisions before
they stopped dividing (Figs. 6C and 7A); with 9 typical
clones shown in Fig. 6C. We studied a total of 38 clones at
37°C and 22 clones at 33°C during these experiments; 12%
of the cells at 37°C died while 9% of cells at 33°C died.
When cells that had been cultured for 11 days at 33°C in
serum-free medium were switched to 37°C and DMEM–
FCS, they failed to proliferate (Fig. 7B), suggesting that they
had stably withdrawn from the cell cycle after 11 days at
33°C, as was the case at 37°C. These findings suggest that
the intrinsic mechanism that limits myocyte proliferation
in vitro does not count cell divisions, but instead measures
time in some other way.
Role of p27 in Cell Cycle Withdrawal
p272/2 mice have excessive numbers of cells in their
organs, including the heart (Fero et al., 1996). This finding
suggests that p27 may be a component of the timing
mechanisms that control when cells stop dividing and
differentiate in many cell lineages. If this is the case, then
developing p272/2 cardiac myocytes would be expected to
go through more divisions before stopping under our cul-
ture conditions than do wild-type cardiac myocytes.
Figure 8A shows that cardiac myocytes isolated from E14
p272/2 mice proliferated more than cells isolated from
p271/1 littermates. Moreover, p272/2 cardiac myocytes
tended to form larger clones in cultures than did p271/1
FCS. The following day the cells were washed and serum-free
medium containing FGF-1 and FGF-2 (25 ng/ml of each), with or
without T3 (30 nM). The cells were fed every 4 days. (A) At the
indicated times, cells were removed from the culture plate and
counted. (B) The day after plating representative cultures were
stained for sarcomeric actin, demonstrating that .98% of the cells
in the cultures were actin-positive cardiac myocytes. Scale bar, 20
mm. (C) After 11 days in serum-free medium, with or without T3,
some E15 cells were switched to DMEM–FCS and counted after a
further 4 days. Data are shown as means 6 SE of four cultures. The
experiment was repeated three times with the same result.FIG. 3. Proliferation of E15 or E21 cardiac myocytes in serum-free
* indicates a significant difference (P , 0.05) compared to the value
ithout T3, when analyzed by Student’s t test.
s of reproduction in any form reserved.
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664 Burton et al.cardiac myocytes, 50% of clones being five cells or greater
at 7 days compared to only 10% of p271/1 clones (Fig. 8B).
Although p27 seems to play a part in stopping the
cell-cycle in developing cardiac myocytes, the amount of
p27 in these cells did not seem to increase in p271/1 cells,
s they proliferated in culture, as assessed by Western
lotting (Fig. 8C). When we immunostained the cells for
FIG. 4. E15 cardiac myocytes cease proliferating on schedule, but
hypertrophy when stimulated with FCS. Cells were maintained in
serum-free DMEM containing FGFs plus T3 for 11 days. Cells were
then switched to DMEM–FCS (arrow). Cell number was counted
and cell size was determined by photographing the cultured cells
and carefully cutting out 10 representative cardiac myocytes for
each time point from photographs and then weighing the photo-
graphic paper. Inset shows cell size on days 2 and 16 of the
experiment; cells taken on days 2, 4, and 8 of the experiment were
homogenized in lysis buffer and Western blotted with affinity-
purified antibodies against Glut-4. Data are shown as means 6 SE
of four cultures.
FIG. 5. Clonal analysis of cardiac myocyte proliferation. E15 or E
r (B) serum-free medium containing FGFs and T3 for 7 days. After this t
ounted in (A) and 163 in (B).
Copyright © 1999 by Academic Press. All right27 and examined them in the confocal microscope, how-
ver, the ratio of nuclear to cytoplasmic p27 progressively
ncreased as the cells proliferated—from 1.1:1 after 2 days to
.2:1 after 6 days in cultures (Fig. 8D). This finding raised
he possibility that the accumulation of p27 in the nucleus
ay help the cells withdraw from the cell cycle. Although
272/2 cardiac myocytes proliferated more than wild-type
ells in serum-free medium containing FGF-1 and -2 plus
3, when we switched such cells to medium containing
0% FCS after 7 days, they did not proliferate further (Fig.
E), suggesting that p27 is not required for stable cell-cycle
xit.
Increase in p18 during Cardiac Myocyte
Development
The phenotype of the p182/2 mouse is remarkably
imilar to that of the p272/2 mouse and loss of both genes
esults in an even more exaggerated phenotype in a number
f organs, including the heart (Franklin et al., 1998). We
herefore studied the expression of p18 protein by Western
lotting during heart development in vivo and in cardiac
myocyte development in vitro. As shown in Fig. 9A we
could not detect p18 in E12, E15, or adult heart, but could
readily detect it in perinatal heart. Similarly, in cultured
E15 cardiac myocytes, p18 levels were maximal after 3–6
days in vitro and then declined (Fig. 9B). These data are
consistent with the possibility that p18 plays a part in
stopping cell division in developing cardiac myocytes; it
seems unlikely, however, that p18 plays a part in maintain-
ing the postmitotic state in the adult heart.
Effect of T3 on p27 and p18 Levels
As p27 and p18 may play a part in stopping cardiac
myocyte cell division and T3 may play a part in helping
yocytes were cultured at clonal density in either (A) DMEM–FCS21 m
ime the number of cells in each clone was counted; 85 clones were
s of reproduction in any form reserved.
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665Timing of Cell-Cycle Withdrawal in Cardiac Myocytesthese cells stably withdraw from the cell-cycle we investi-
gated the effect of T3 on the expression of p18 and p27. As
shown in Fig. 10, T3 did not affect the level of p27, but
seemed to be required for the expression of p18.
DISCUSSION
FIG. 6. Time-lapse video analysis of myocyte proliferation. E15
myocytes were cultured at clonal density in 25-cm2 flasks in
erum-free medium containing FGFs and T3 at 37°C (A). After 7–10
ays, pedigrees were constructed from the time-lapse videotapes. H
ndicates cells for which no further cell divisions were observed
uring the time course of the experiment; [ \ ] indicates cells that
ied. Free-ending lines indicate cells that migrated out of the field
f view. The clones are grouped according to the maximum number
f cell divisions. (B) Cell-cycle length was measured in serum-free
edium containing FGFs and T3 at either 37 or 33°C. Ten cell
ivisions were examined for each determination, and the data are
hown as means 6 SD. (C) Clonal analysis of E15 cardiac myocytes
aintained at 33°C. The symbols are the same as in A.To investigate the nature of the mechanisms that nor-
mally arrest cell division in developing cardiac myocytes,
Copyright © 1999 by Academic Press. All righte have found culture conditions under which fetal rat
ardiac myocytes stop dividing on roughly the same sched-
le in vitro as in vivo. Whereas the cells proliferate exces-
ively in the presence of 10% FCS, they go through about
he normal number of divisions in serum-free medium
ontaining FGF-1, FGF-2, and T3 as well as other supple-
ents. As in vivo, the myocytes that stop dividing under
hese conditions apparently withdraw from the cell cycle
ermanently, as even when they are subsequently stimu-
ated by 10% FCS they no longer divide, although they do
nlarge and further differentiate, as they do after withdraw-
ng from the cell cycle in vivo. Western blot analysis
ndicates that both FGF-1 and FGF-2 are present in the
eveloping rat heart, suggesting that they both may help
timulate myocyte proliferation during normal heart devel-
pment. As both FGFs continue to increase in the postnatal
eart after the myocytes have stopped dividing, it is pos-
ible that these factors act to induce hyperplastic growth
uring fetal life and hypertrophic growth postnatally (Schei-
owitz et al., 1998; Fukuda and Izumo, 1998; Disatnik et
l., 1995).
Role of T3
T3 seems to help the myocytes permanently stop divid-
ing, as in its absence, the cells arrest on schedule under the
serum-free conditions, but when they are switched to
serum-containing medium, they can divide again. T3 has
also been shown to trigger E18 rat cardiac myocytes in
culture to switch from the expression of the b isoform of
yosin heavy chain to the a isoform (Gustafson et al.,
1987), a change that occurs during normal cardiac myocyte
maturation in vivo (Robbins, 1996).
Interestingly, cardiac myocytes stop dividing when de-
rived of FGFs in culture, but they do not permanently
rrest, as they divide again when stimulated by FCS, even
fter many days in vitro without mitogen. In this respect,
hey differ from oligodendrocyte precursor cells which
apidly and permanently withdraw from the cell cycle and
ifferentiate when deprived of their main mitogen, PDGF.
hether cardiac myocytes require some cell cycling to
nitiate the timing mechanism remains to be determined.
Intrinsic Timer
Like oligodendrocyte precursor cells, cardiac myocytes
seem to have an intrinsic mechanism that limits their
proliferation. Two lines of evidence support this suggestion.
First, the proliferative capacity of young myocytes is greater
than that of older myocytes, even when they are cultured
under the same conditions: E12 myocytes proliferate more
in culture than do E15 myocytes, which, in turn, proliferate
more than do E21 myocytes. Our clonal analyses indicate
that even myocytes isolated from the same age hearts are
heterogeneous in their proliferative capacity: some E15
myocytes, for example, divide only once when stimulated
s of reproduction in any form reserved.
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666 Burton et al.by FGFs in our serum-free medium, whereas others divide
seven times (see Fig. 5B). The simplest explanation for this
interclonal heterogeneity is that it reflects heterogeneity in
maturation, as would be expected if cells commit to cardiac
myocyte development over a prolonged period (Rumyant-
sev, 1978). The second line of evidence that developing
myocytes have an intrinsic mechanism that limits their
proliferation comes from our time-lapse video studies,
which indicate that two daughter cells produced by a cell
division tend to go through the same number of divisions
before they stop dividing. It is unlikely that this intraclonal
homogeneity reflects cell–cell interactions within clones,
as some of the clones contained only two cells that moved
apart after they divided and did not contact each other
again. Taken together, these data argue strongly for a
cell-intrinsic timing mechanism contributing to cell cycle
withdrawal in cardiac myocytes.
Although most cells within a clone divide again at around
the same time, occasionally the two daughter cells of a
division divide again at very different times. In each of these
cases the cell division that produced the two daughter cells
was asymmetrical, with the larger daughter dividing before
the smaller. Similar findings have been reported previously
for yeast cells (Fantes and Nurse, 1977), amoebae (Prescott,
1956), Tetrahymena (Prescott, 1959), some mammalian cell
ines (Killander and Zetterberg, 1965), and oligodendrocyte
recursor cells (Gao and Raff, 1997). It seems that prolifer-
ting myocytes, like many other proliferating cell types,
ay have to grow to a critical size before they can divide.
he molecular basis of such size control is still uncertain;
owever, the use of hypertrophic agonists such as angioten-
in II (Fukuda and Izumo, 1998) may be useful in further
nvestigating this hypothesis.
FIG. 7. E15 myocytes cultured at 33°C stop proliferating at the sa
were cultured in serum-free medium containing FGFs and T3 at
maintained at either temperature for 11 days were refed with D
determined. Data are shown as means 6 SE of four cultures. TheTo help determine whether the intrinsic mechanism that
imits proliferation of cardiac myocytes operates by count-
Copyright © 1999 by Academic Press. All rightng cell divisions, we made use of a strategy that was used
nitially by Jat and his colleagues in studies of replicative
enescence in mouse embryo fibroblasts (MEFs) in culture
Ikram et al., 1994) and later by Gao et al. (1997) in studies
f oligodendrocyte precursor cell differentiation. In both
ases it was found that the cells stopped dividing sooner,
fter fewer divisions, at 33 than at 37°C, suggesting that the
echanisms that limit cell proliferation in these cases do
ot operate by counting cell divisions. We find a similar
ffect of low temperature on cardiac myocytes, suggesting
hat the mechanism that limits cell proliferation in these
ells also does not count cell divisions, but, instead, mea-
ures time in some other way. Unlike MEFs and oligoden-
rocyte precursor cells, however, although the myocytes
ivide more slowly at 33 than at 37°C, they stop dividing at
round the same time at the two temperatures, suggesting
hat the myocyte timer does not run faster at the lower
emperature. Nameroff and his colleagues have suggested
hat chick skeletal myoblasts use a cell-division counting
echanism to determine when they will stop dividing and
ifferentiate (Quinn et al., 1985). The results of their clonal
nalyses, however, are also compatible with a mechanism
hat measures time. It would be interesting to compare
keletal myoblast development at 33 and 37°C.
Role of CDK Inhibitors
Analyses of the phenotype of the p27- and p18-deficient
mice suggest that these CDK inhibitors normally play a
part in determining when various types of precursor cells
exit the cell cycle and terminally differentiate (Franklin
et al., 1998; Fero et al., 1996; Kiyokawa et al., 1996;
Nakayama et al., 1996). In both types of mutant mice the
ime, but after fewer divisions, as when cultured at 37°C. (A) Cells
r 33 or 37°C and were counted at various time points. (B) Cells
–FCS for a further 4 days, and the increase in cell number was
iments were repeated three times with similar results.me t
eitheheart is larger and contains more cells, and in mutants
deficient in both p18 and p27 the heart is even larger
s of reproduction in any form reserved.
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667Timing of Cell-Cycle Withdrawal in Cardiac MyocytesFIG. 8. Role of p27. (A) Cardiac myocytes were isolated from E14 mice and maintained in serum-free medium containing FGFs and T3.
After 7 days the number of cells in cultures was determined and compared to the number of cells present on day 1. Data are shown as
means 6 SE of four cultures. The experiment was repeated twice with similar results. * indicates a significant difference (P , 0.05,
tudent’s t test) compared to the wild-type value. (B) Cells were cultured at clonal density in 60-mm petri dishes. After 7 days the number
f cells in 42 (p271/1) and 38 (p272/2) randomly selected clones was determined. An F test for analysis of variance between the two groups
howed them to be significantly different (P , 0.05). (C) Total cell extracts were prepared from E15 rat cardiac myocytes maintained for the
ndicated number of days in culture as described in Fig. 3. Extracts were then analyzed by Western blotting using antibodies against p27
nd sarcomeric actin. (D) Cells were cultured as in (A). After 2 or 6 days they were stained for p27, and the ratio of p27 in the nucleus and
ytoplasm in 30 randomly selected cells was determined using confocal microscopy. Data are shown as means 6 SE. * indicates a
ignificant difference (P , 0.05, Student’s t test) compared to day 2. (E) Cells were cultured as in (A). After 7 days they were switched into
edium containing 10% FCS, and the number of cells was determined after a further 7 days. Data are shown as means 6 SE of four cultures.
he experiment was repeated twice with similar results.
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668 Burton et al.(Franklin et al., 1998). However, the expression of p21,
p27, and p57 during rat heart development is difficult to
correlate with cell-cycle withdrawal (Burton et al., 1999;
Koh et al., 1998; Poolman and Brooks, 1998). p21 expres-
sion is highest in the adult heart, and p57 expression
declines sharply after E15. Moreover, levels of p21 did not
change and p57 remained undetectable in cultured myo-
cytes under the conditions described here (data not
shown). In agreement with this the hearts of mice lacking
both p21 and p57 appear normal (P. B. J. Burton and P.
Zhang, unpublished observation). p27 levels are consis-
tently elevated (Burton et al., 1999). However, Poolman
and colleagues (1999) have shown that adult p27-
deficient mice have two- to three-fold more cardiac
myocytes than wild-type mice, apparently because devel-
oping cardiac myocytes continue to proliferate for longer
in the mutants. Our findings support this interpretation.
In both bulk and clonal cultures we find that p27-
deficient cardiac myocytes proliferate more than do wild-
type myocytes, although they do eventually stably with-
draw from the cell cycle. Although p27-deficient
oligodendrocyte precursor cells divide with a normal
cell-cycle time, many of them go through one or two
more divisions than do wild-type cells before they stop
and differentiate (Durand et al., 1997). In wild-type
oligodendrocyte precursor cells the level of p27 protein
FIG. 9. Western blot analysis of p18. (A) The proteins in heart
extracts were separated by SDS–PAGE, blotted onto nitrocellulose,
and probed with affinity-purified antibodies against p18 and sarco-
meric actin. The same amount of total protein (30 mg) was loaded
n each lane. (B) E15 rat cardiac myocytes cultured in serum-free
edium containing FGFs and T3 for the indicated time and then
nalyzed by Western blotting, as in (A). The experiment was
epeated twice, with the same result.assessed by immunocytochemistry has been shown to
progressively increase as the cells proliferate in culture
Copyright © 1999 by Academic Press. All right(Durand et al., 1997), but we have been unable to dem-
onstrate a similar increase in p27 in proliferating cardiac
myocytes in culture using Western blotting. When we
use immunocytochemistry to study the intracellular
location of p27 in cultured cardiac myocytes, however,
we find that the ratio of nuclear to cytoplasmic p27
progressively increases, raising the possibility that the
accumulation of p27 in the nucleus plays a part in
stopping the cell cycle. A cytoplasmic localization of p27
has also been reported in transformed fibroblasts and
several human tumor cell lines (Orend et al., 1998),
including esophageal adenocarcinoma cells, in which it is
associated with an especially poor prognosis. In addition,
as myeloid cells differentiate the cellular distribution of
p27 changes from nuclear, to cytoplasmic, and finally to
perinuclear (Yaroslavskiy et al., 1999). Thus the location
of p27 within the cell may be important for its role in
regulating differentiation processes.
We also find that the expression of p18 closely parallels
perinatal cardiac myocyte cell cycle withdrawal. p18 is
undetectable by Western blotting in extracts of E12 and
E15 rat heart, but is readily detectable from E17 onward,
although it is no longer detectable in adult heart. Inter-
estingly, the increase in p18 seen in E15 cardiac myocytes
in vitro depends on the presence of T3 in the culture
medium. Given the requirement of these cells on T3 for
stable cell-cycle exit, this finding may provide a potential
link between T3 and stable cell-cycle withdrawal in these
cells. It would therefore be interesting to examine the
behavior of cardiac myocytes deficient for p18.
In summary, we have provided evidence that developing
cardiac myocytes have an intrinsic timing mechanism that
helps determine when these cells stop dividing and we have
explored the possibility that p18, p27, and T3 are involved
in the stopping process.
FIG. 10. Western blot analysis showing the effect of T3 on p18,
p21, p27, and p57 expression in cardiac myocytes in culture. E15 rat
cardiac myocytes were cultured in serum-free medium containing
FGFs and T3 for 3 or 6 days. Extracts were then analyzed as in Fig.
9, using antibodies against p18, p21, p27, and p57. The experiment
was performed twice with the same result.
s of reproduction in any form reserved.
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